IBDEI13D ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18226,1,3,0)
 ;;=3^Furuncle,Unspec
 ;;^UTILITY(U,$J,358.3,18226,1,4,0)
 ;;=4^L02.92
 ;;^UTILITY(U,$J,358.3,18226,2)
 ;;=^5009017
 ;;^UTILITY(U,$J,358.3,18227,0)
 ;;=L02.93^^94^905^93
 ;;^UTILITY(U,$J,358.3,18227,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18227,1,3,0)
 ;;=3^Carbuncle,Unspec
 ;;^UTILITY(U,$J,358.3,18227,1,4,0)
 ;;=4^L02.93
 ;;^UTILITY(U,$J,358.3,18227,2)
 ;;=^5009018
 ;;^UTILITY(U,$J,358.3,18228,0)
 ;;=L03.011^^94^905^108
 ;;^UTILITY(U,$J,358.3,18228,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18228,1,3,0)
 ;;=3^Cellulitis of Right Finger
 ;;^UTILITY(U,$J,358.3,18228,1,4,0)
 ;;=4^L03.011
 ;;^UTILITY(U,$J,358.3,18228,2)
 ;;=^5009019
 ;;^UTILITY(U,$J,358.3,18229,0)
 ;;=L03.012^^94^905^101
 ;;^UTILITY(U,$J,358.3,18229,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18229,1,3,0)
 ;;=3^Cellulitis of Left Finger
 ;;^UTILITY(U,$J,358.3,18229,1,4,0)
 ;;=4^L03.012
 ;;^UTILITY(U,$J,358.3,18229,2)
 ;;=^5009020
 ;;^UTILITY(U,$J,358.3,18230,0)
 ;;=L03.021^^94^905^24
 ;;^UTILITY(U,$J,358.3,18230,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18230,1,3,0)
 ;;=3^Acute Lymphangitis of Right Finger
 ;;^UTILITY(U,$J,358.3,18230,1,4,0)
 ;;=4^L03.021
 ;;^UTILITY(U,$J,358.3,18230,2)
 ;;=^5009022
 ;;^UTILITY(U,$J,358.3,18231,0)
 ;;=L03.022^^94^905^18
 ;;^UTILITY(U,$J,358.3,18231,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18231,1,3,0)
 ;;=3^Acute Lymphangitis of Left Finger
 ;;^UTILITY(U,$J,358.3,18231,1,4,0)
 ;;=4^L03.022
 ;;^UTILITY(U,$J,358.3,18231,2)
 ;;=^5009023
 ;;^UTILITY(U,$J,358.3,18232,0)
 ;;=L03.031^^94^905^111
 ;;^UTILITY(U,$J,358.3,18232,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18232,1,3,0)
 ;;=3^Cellulitis of Right Toe
 ;;^UTILITY(U,$J,358.3,18232,1,4,0)
 ;;=4^L03.031
 ;;^UTILITY(U,$J,358.3,18232,2)
 ;;=^5009025
 ;;^UTILITY(U,$J,358.3,18233,0)
 ;;=L03.032^^94^905^104
 ;;^UTILITY(U,$J,358.3,18233,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18233,1,3,0)
 ;;=3^Cellulitis of Left Toe
 ;;^UTILITY(U,$J,358.3,18233,1,4,0)
 ;;=4^L03.032
 ;;^UTILITY(U,$J,358.3,18233,2)
 ;;=^5009026
 ;;^UTILITY(U,$J,358.3,18234,0)
 ;;=L03.041^^94^905^26
 ;;^UTILITY(U,$J,358.3,18234,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18234,1,3,0)
 ;;=3^Acute Lymphangitis of Right Toe
 ;;^UTILITY(U,$J,358.3,18234,1,4,0)
 ;;=4^L03.041
 ;;^UTILITY(U,$J,358.3,18234,2)
 ;;=^5009028
 ;;^UTILITY(U,$J,358.3,18235,0)
 ;;=L03.042^^94^905^20
 ;;^UTILITY(U,$J,358.3,18235,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18235,1,3,0)
 ;;=3^Acute Lymphangitis of Left Toe
 ;;^UTILITY(U,$J,358.3,18235,1,4,0)
 ;;=4^L03.042
 ;;^UTILITY(U,$J,358.3,18235,2)
 ;;=^5009029
 ;;^UTILITY(U,$J,358.3,18236,0)
 ;;=M34.0^^94^905^249
 ;;^UTILITY(U,$J,358.3,18236,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18236,1,3,0)
 ;;=3^Progressive Systemic Sclerosis
 ;;^UTILITY(U,$J,358.3,18236,1,4,0)
 ;;=4^M34.0
 ;;^UTILITY(U,$J,358.3,18236,2)
 ;;=^5011778
 ;;^UTILITY(U,$J,358.3,18237,0)
 ;;=M34.1^^94^905^91
 ;;^UTILITY(U,$J,358.3,18237,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18237,1,3,0)
 ;;=3^CR(E)ST Syndrome
 ;;^UTILITY(U,$J,358.3,18237,1,4,0)
 ;;=4^M34.1
 ;;^UTILITY(U,$J,358.3,18237,2)
 ;;=^5011779
 ;;^UTILITY(U,$J,358.3,18238,0)
 ;;=M34.2^^94^905^273
 ;;^UTILITY(U,$J,358.3,18238,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18238,1,3,0)
 ;;=3^Systemic Sclerosis Induced by Drug/Chemical
 ;;^UTILITY(U,$J,358.3,18238,1,4,0)
 ;;=4^M34.2
 ;;^UTILITY(U,$J,358.3,18238,2)
 ;;=^5011780
 ;;^UTILITY(U,$J,358.3,18239,0)
 ;;=M34.81^^94^905^275
 ;;^UTILITY(U,$J,358.3,18239,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18239,1,3,0)
 ;;=3^Systemic Sclerosis w/ Lung Involvement
